Navigation Links
More than fish bait: Worms unlock secrets to new epilepsy treatments

A team of scientists from The University of Alabama used worms to reel in information that they hope will lead to a greater understanding of cellular mechanisms that may be exploited to treat epilepsy. In a new research report in the journal GENETICS (, the researchers explain how the transparent roundworm, C. elegans, helped them identify key "molecular switches" that control the transport of a molecule (gamma-aminobutyric acid or "GABA") that if manipulated within our cells, might prevent the onset of seizures.

"It is our hope that this work serves to accelerate the path toward the identification of genetic factors that cause a susceptibility to epilepsy," said Guy A. Caldwell, Ph.D., co-author of the study from the Department of Biological Sciences at The University of Alabama in Tuscaloosa. "Simultaneously, this work has the potential to uncover new avenues toward therapeutic development to control or prevent seizures in the future."

To make this finding, the researchers conducted experiments involving drugs known to affect neuronal activity in combination with DNA mutations in genetic factors shared between C. elegans and humans. Changes in the worm's neuronal activity led to repetitive convulsions believed to be similar to those experienced in epilepsy. These convulsions were observed under a microscope, and videos of those events were used to evaluate the severity of the neuronal changes. At the same time, the researchers used a green fluorescent protein to "tag" or "label" the cellular locale and delivery of GABA in neurons. This tagging allowed the researchers to see the specific genetic factors that led to abnormal movement of GABA in neurons as they coincided with worm seizures and to make appropriate comparisons with worms from the control group.

"Although much more work must be done before new drugs can be developed for people, these findings could offer hope to people with this devastating and frustrating condition," said Mark Johnston, Editor-in-Chief of GENETICS. "It may be hard to believe, but the cellular processes that occur in these worms are likely to be similar to those in humans. This work has the potential to significantly advance our understanding of what causes seizures in people, and could point the way to a remedy."


Contact: Tracey DePellegrin Connelly
Genetics Society of America

Related biology news :

1. Scientists alter sexual orientation in worms
2. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
3. Worms take the sniff test to reveal sex differences in brain
4. Snoozing worms help Penn researchers explain the evolution of sleep
5. After more than 100 years apart, webworms devastate New Zealand parsnips
6. Rusty worms in the brain
7. Rutgers biologist to study worms in Amazon, glaciers
8. Sex and lifespan linked in worms
9. Almost 7 million pregnant in sub-Saharan Africa infected with hookworms; at risk of anaemia
10. Longevity, cancer and diet connected: New research in worms could apply to humans
11. Floridas worm grunters collect bait worms by inadvertently imitating mole sounds
Post Your Comments:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:10/29/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that it has been ... one of only three finalists for a 2015 ... Growing" category. The Tekne Awards honor Minnesota ... innovation and leadership. iMedNet™ eClinical ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology: